ZNF774 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.15889999818819E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.07920000012174E-07 |
Normal-vs-Stage2 |
2.125000E-03 |
Normal-vs-Stage3 |
2.69162470090123E-12 |
Normal-vs-Stage4 |
4.038300E-04 |
Stage1-vs-Stage2 |
7.133000E-01 |
Stage1-vs-Stage3 |
2.02220000000697E-06 |
Stage1-vs-Stage4 |
1.637450E-01 |
Stage2-vs-Stage3 |
8.561800E-02 |
Stage2-vs-Stage4 |
3.691000E-01 |
Stage3-vs-Stage4 |
7.708400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.59130000685093E-09 |
Normal-vs-AfricanAmerican |
3.404600E-03 |
Normal-vs-Asian |
6.004600E-01 |
Caucasian-vs-AfricanAmerican |
1.850180E-01 |
Caucasian-vs-Asian |
1.642960E-01 |
AfricanAmerican-vs-Asian |
3.839200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.53709999675777E-08 |
Normal-vs-Female |
3.44730000101379E-08 |
Male-vs-Female |
5.637200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.905900E-02 |
Normal-vs-Age(41-60Yrs) |
8.70600003199939E-09 |
Normal-vs-Age(61-80Yrs) |
1.13459999950827E-07 |
Normal-vs-Age(81-100Yrs) |
1.52235999999473E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.578200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.072000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.180000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.585800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.069200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.380000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.979200E-01 |
Normal-vs-Grade 2 |
7.69470000050454E-07 |
Normal-vs-Grade 3 |
1.20920000012958E-07 |
Normal-vs-Grade 4 |
2.45010001176382E-09 |
Grade 1-vs-Grade 2 |
3.490100E-02 |
Grade 1-vs-Grade 3 |
6.258200E-02 |
Grade 1-vs-Grade 4 |
3.241800E-03 |
Grade 2-vs-Grade 3 |
1.087390E-01 |
Grade 2-vs-Grade 4 |
1.461970E-03 |
Grade 3-vs-Grade 4 |
1.084180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.82880000044028E-07 |
Normal-vs-ccB subtype |
4.5539999549149E-09 |
ccA subtype-vs-ccB subtype |
4.613900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.91009999986436E-07 |
Normal-vs-N1 |
4.12750000000628E-05 |
N0-vs-N1 |
2.478200E-01 |
|
|